AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021
Apr 6, 2021
32163_dirs_2021-04-05_a62dc2a1-b3f2-40bd-9387-61beb2f49eeb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-04-01
Reporting Person: Fleming Alison B (EVP & Chief Technical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-01 | Common Stock | F | 1757 | $23.38 | Disposed | 152980 | Direct |
| 2021-04-01 | Common Stock | F | 7900 | $23.38 | Disposed | 145080 | Direct |
Footnotes
F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units.
F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
More from COLLEGIUM PHARMACEUTICAL, INC
Share Issue/Capital Change
2026
Jun 1
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Board/Management Information
2026
Apr 7
Major Shareholding Notification
2026
Mar 26